Voya Investment Management LLC Aeglea Bio Therapeutics, Inc. Transaction History

Voya Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.5 - $2.66 $7,733 - $41,139	-15,466 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$3.5 - $8.42 $15,442 - $37,149	-4,412 Reduced 22.2%	15,466 $73,000
Q2 2021 Aug 16, 2021	SELL	$6.32 - $8.38 $10,213 - $13,542	-1,616 Reduced 7.52%	19,878 $138,000
Q1 2021 May 17, 2021	BUY	$6.76 - $8.57 $25,350 - $32,137	3,750 Added 21.13%	21,494 $170,000
Q4 2020 Feb 16, 2021	BUY	$7.02 - $9.83 $16,960 - $23,749	2,416 Added 15.76%	17,744 $140,000
Q2 2020 Aug 14, 2020	BUY	$4.01 - $11.04 $6,532 - $17,984	1,629 Added 11.89%	15,328 $142,000
Q4 2019 Feb 14, 2020	BUY	$7.23 - $8.55 $99,043 - $117,126	13,699 New	13,699 $105,000

241K

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.